Skip to main content

and
  1. No Access

    Chapter

    The management of bladder cancer — a case history

    Bladder cancer is a common disease, accounting worldwide for approximately 3.5% of all new cancers. It manifests a wide spectrum of disease, ranging from a solitary, papillary, non-invasive lesion, through to ...

    A. P. M. Lydon, S. J. Harland, G. M. Duchesne in The Teaching Cases from Annals of Oncology (1997)

  2. No Access

    Chapter

    The Development of Resistance to Methotrexate in a Human Leukaemia (AML) Growing in Nude Mice

    The line was derived by s. c. implantation of 2.4 x 106 leukaemic cells. The resultant solid tumour was shown to be sensitive to methotrexate at its third passage. Development of the resistant line commenced at p...

    M. Jones, S. J. Harland, S. Sparrow in Cancer Chemotherapy and Selective Drug Development (1984)

  3. No Access

    Chapter

    JM8 Development and Clinical Projects

    Since its introduction in the early 1970’s cisplatin has become established as one of the major cytotoxic drugs used in the treatment of cancer. Of particular note are its application in combination therapy to...

    A. H. Calvert, S. J. Harland, K. R. Harrap in Platinum Coordination Complexes in Cancer … (1984)